Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome): Case Report

Year 2016, Volume: 13 Issue: 1, 84 - 87, 28.04.2016

Hakan Tanrıverdi Fırat Uygur Bülent Altınsoy , Fatma Erboy , Ömer Yazgan Figen Atalay

Abstract

Eosinophilic granulomatosis with polyangiitis (EGPA) is a systemic necrotizing vasculitis characterized by
tissue and blood eosinophilia. Several drugs including leukotriene receptor antagonists (LTRAs) are
suspected to trigger EGPAdevelopment. Here, we present a case of EGPAunrelated to LTRAs.

Keywords

Eosinophilia, Leukotriene Receptor Antagonists, Eosinophilic Granulomatous, Vasculitis

Polianjitisle Seyreden Eozinofilik Granülomatozis (Churg Strauss Sendromu): Olgu Sunumu

Abstract

Polianjitisle birlikte seyreden eozinofilik granülomatozis (Churg Strauss sendromu), nadir, sıklıkla solunum
sistemini tutan ve özellikle küçük ve orta çaplı damarları etkileyen, astım ve doku eozinofilisi ile karakterize,
sistemik nekrotizan bir vaskülittir. Lökotrien antagonistlerini de içeren pek çok ilacın bu hastalığın
gelişiminde rolü olduğundan şüphelenilmektedir. Biz de klinik ve radyolojik bulgularla tanı alan ve lökotrien
reseptör antagonistleri ile ilişkili olmadığını düşündüğümüz bir olguyu sunmak istedik. 

Keywords

Eozinofili, lökotrien reseptör antagonisti, eozinofilik granülamatöz, Vaskülit

References

• 1.Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V et al. Eosinophilic granulomatosis with polyangiitis (Churg–Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26 (7):545-53. http://dx.doi.org/10.1016/j.ejim.2015.04.022
• 2.Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Stern M et al. Long-term outcomes of 118 patients with eosinophilic granulomatosis with polyangiitis (ChurgStrauss syndrome) enrolled in two prospective trials. J Autoimmun 2013;43:60-9.
• 3.Ramentol-Sintas M, Martínez-Valle F, Solans-Laqué R. Churg–Strauss Syndrome: An evolving paradigm. Autoimmun Rev 2012;12(2):235–40. Masi AT 1
• 4. , Hunder GG, Lie JT, Michel BA, Bloch DA, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum. 1990;33(8):1094-100.
• 5.Yıldız F, Zorludemir S, Erken E. Montelukast ilişkili Churg Strauss sendromu: Üç olgu. Cukurova Med J 2014;39(2):347-52
• 6.Bibby S, Healy B, Steele R, Kumareswaran K, Nelson H, Beasley R. Association between leukotriene receptor antagonist therapy and Churg–Strauss syndrome: an analysis of the FDA AERS database. Thorax 2010;65(2):132–8
• 7.Hauser T, Mahr A, Metzler C, Coste J, Sommerstein R, Gross WL, e t a l. The l eucotri ene r e c eptor antagonistmontelukast and the risk of Churg–Strauss Sy n d r ome : a c a s e - c r o ss o v e r st u d y. Th o r a x 2008;63(8):677–82.
• 8.Abril A, Calamia KT, Cohen MD. The Churg Strauss syndrome (Allergic granulomatous angiitis): Review and update. Semin Arthritis Rheum 2003;33:106-14.